Finance

Beta
Lists
QGI:FRA
Mitra Adiperkasa Tbk PT
€0.062
0.00%
(0.00) 1D
Jun 3, 8:05:12 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for QGI...
Open
€0.06
High
€0.06
Low
€0.06
Mkt. cap
24.82T
Avg. vol.
37.00
Volume
0.00
52-wk high
€0.08
52-wk low
€0.04
No. of employees
34K
Open
€0.06
High
€0.06
Low
€0.06
Mkt. cap
24.82T
Avg. vol.
37.00
Volume
0.00
52-wk high
€0.08
52-wk low
€0.04
No. of employees
34K
News stories
From sources across the web
About Mitra Adiperkasa Tbk PT
CEOVirendra Prakash Sharma
Employees34K
Founded1995
Headquarters-
SectorConsumer
Websitemap.co.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
10.26T
10.48T
13.05T
12.29T
Cost of goods sold
6.14T
6.25T
7.96T
7.53T
Cost of revenue
6.14T
6.25T
7.96T
7.53T
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.27T
3.36T
3.67T
3.71T
Operating expense
3.27T
3.36T
3.67T
3.71T
Total operating expenses
9.41T
9.61T
11.63T
11.24T
Operating income
851.29B
864.32B
1.41T
1.05T
Other non operating income
20.60B
-2.00B
14.77B
-17.57B
EBT including unusual items
797.94B
747.47B
1.34T
941.39B
EBT excluding unusual items
800.82B
753.08B
1.38T
943.44B
Income tax expense
219.68B
189.93B
320.55B
179.12B
Effective tax rate
27.53%
25.41%
23.97%
19.03%
Other operating expenses
-
-
-
-
Net income
488.66B
413.86B
856.37B
628.04B
Net profit margin
4.76%
3.95%
6.56%
5.11%
Earnings per share
29.00
25.00
51.00
38.00
Interest and investment income
29.80B
23.84B
26.38B
32.82B
Interest expense
-147.35B
-138.86B
-133.04B
-143.22B
Net interest expenses
-117.55B
-115.02B
-106.66B
-110.40B
Depreciation and amortization charges
-
-
-
-
EBITDA
1.16T
1.15T
1.76T
1.38T
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer